Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
87718146 |
LAW OFFICE ASSIGNED |
LAW OFFICE 125 |
MARK SECTION |
MARK |
ZYNRELEF (see, http://uspto.report/TM/87718146/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ZYNRELEF |
OWNER SECTION (current) |
NAME |
Heron Therapeutics, Inc. |
MAILING ADDRESS |
4242 Campus Point Court, Suite 200 |
CITY |
San Diego |
STATE |
California |
ZIP/POSTAL CODE |
92121 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Heron Therapeutics, Inc. |
MAILING ADDRESS |
4242 Campus Point Court, Suite 200 |
CITY |
San Diego |
STATE |
California |
ZIP/POSTAL CODE |
92121 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
Beth M. Goldman |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
ORRICK, HERRINGTON & SUTCLIFFE LLP |
INTERNAL ADDRESS |
IP Prosecution Department |
STREET |
2050 Main Street, Suite 1100 |
CITY |
IRVINE |
STATE |
California |
POSTAL CODE |
92614-8255 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
415-773-5700 |
FAX |
415-773-5759 |
EMAIL |
ipprosecutionsf@orrick.com |
DOCKET/REFERENCE NUMBER |
21539-6000 |
ATTORNEY INFORMATION (proposed) |
NAME |
Beth M. Goldman |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
ORRICK, HERRINGTON & SUTCLIFFE LLP |
INTERNAL ADDRESS |
IP Prosecution Department |
STREET |
2050 Main Street, Suite 1100 |
CITY |
IRVINE |
STATE |
California |
POSTAL CODE |
92614-8255 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
415-773-5700 |
FAX |
415-773-5759 |
EMAIL |
ipprosecutionsf@orrick.com |
DOCKET/REFERENCE NUMBER |
21539-6000 |
OTHER APPOINTED ATTORNEY |
Betsy Wang Lee, Eileen Z. Aghnami, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M. Wright, Robert M. O'Connell Jr. |
CORRESPONDENCE INFORMATION (current) |
NAME |
BETH M. GOLDMAN |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ipprosecutionsf@orrick.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; ccivil@orrick.com |
DOCKET/REFERENCE NUMBER |
21539-6000 |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Beth M. Goldman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ipprosecutionsf@orrick.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com |
DOCKET/REFERENCE NUMBER |
21539-6000 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics;
local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for
peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain; all of the foregoing excluding pharmaceutical
preparations and substances for treatment or management of sleep disorders, namely, narcolepsy |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research or development ; market research ; promotional activities |
ALLOWANCE MAIL DATE |
11/06/2018 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Thomas Ottoboni/ |
SIGNATORY'S NAME |
Ottoboni, Thomas |
SIGNATORY'S POSITION |
Senior VP |
DATE SIGNED |
04/16/2020 |
SIGNATORY'S PHONE NUMBER |
N/A |
FILING INFORMATION |
SUBMIT DATE |
Thu Apr 16 14:32:41 ET 2020 |
TEAS STAMP |
USPTO/ESU-X.XX.XXX.X-2020
0416143241602707-87718146
-710531162e2e0d7eb335f4d7
5e9323d827133d323b2675a35
ebe6d953dd86c9-DA-3241224
6-20200416104806886644 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ZYNRELEF (see, http://uspto.report/TM/87718146/mark.png)
SERIAL NUMBER: 87718146
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Heron Therapeutics, Inc., having an address of
4242 Campus Point Court, Suite 200
San Diego, California 92121
United States
Proposed: Heron Therapeutics, Inc., having an address of
4242 Campus Point Court, Suite 200
San Diego, California 92121
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 11/06/2018.
For International Class 005:
Current identification: Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics; local anesthetics; topical
anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and
post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain; all of the foregoing excluding pharmaceutical preparations and
substances for treatment or management of sleep disorders, namely, narcolepsy
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development ; market research ; promotional activities
The applicant's current Attorney Information:
Beth M. Goldman ORRICK, HERRINGTON & SUTCLIFFE LLP
IP Prosecution Department
2050 Main Street, Suite 1100
IRVINE, California 92614-8255
United States
Phone: 415-773-5700
Fax: 415-773-5759
The docket/reference number is 21539-6000
Email: ipprosecutionsf@orrick.com
The applicant's proposed Attorney Information:
Beth M. Goldman ORRICK, HERRINGTON & SUTCLIFFE LLP
IP Prosecution Department
2050 Main Street, Suite 1100
IRVINE, California 92614-8255
United States
Phone: 415-773-5700
Fax: 415-773-5759
The docket/reference number is 21539-6000
Email: ipprosecutionsf@orrick.com
Correspondence Information (current):
BETH M. GOLDMAN
PRIMARY EMAIL FOR CORRESPONDENCE: ipprosecutionsf@orrick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; ccivil@orrick.com
Correspondence Information (proposed):
Beth M. Goldman
PRIMARY EMAIL FOR CORRESPONDENCE: ipprosecutionsf@orrick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Thomas Ottoboni/ Date Signed: 04/16/2020
Signatory's Name: Ottoboni, Thomas
Signatory's Position: Senior VP
Signatory's Phone: N/A
Mailing Address:
ORRICK, HERRINGTON & SUTCLIFFE LLP
IP Prosecution Department
2050 Main Street, Suite 1100
IRVINE, California 92614-8255
RAM Sale Number: 87718146
RAM Accounting Date: 04/16/2020
Serial Number: 87718146
Internet Transmission Date: Thu Apr 16 14:32:41 ET 2020
TEAS Stamp: USPTO/ESU-X.XX.XXX.X-2020041614324160270
7-87718146-710531162e2e0d7eb335f4d75e932
3d827133d323b2675a35ebe6d953dd86c9-DA-32
412246-20200416104806886644